XPONENTIAL FITNESS INC-A (XPOF)

US98422X1019 - Common Stock

12.29  +0.05 (+0.41%)

After market: 12.29 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to XPOF. XPOF was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. There are concerns on the financial health of XPOF while its profitability can be described as average. XPOF is not valued too expensively and it also shows a decent growth rate.



4

1. Profitability

1.1 Basic Checks

XPOF had positive earnings in the past year.
In the past year XPOF had a positive cash flow from operations.
XPOF had negative earnings in 4 of the past 5 years.
XPOF had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 2.92%, XPOF is in line with its industry, outperforming 56.30% of the companies in the same industry.
The Return On Invested Capital of XPOF (13.26%) is better than 82.22% of its industry peers.
Industry RankSector Rank
ROA 2.92%
ROE N/A
ROIC 13.26%
ROA(3y)-4.27%
ROA(5y)-5.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 4.25%, XPOF perfoms like the industry average, outperforming 57.78% of the companies in the same industry.
The Operating Margin of XPOF (18.25%) is better than 74.81% of its industry peers.
XPOF's Gross Margin of 76.74% is amongst the best of the industry. XPOF outperforms 89.63% of its industry peers.
XPOF's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.25%
PM (TTM) 4.25%
GM 76.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.14%
GM growth 5Y6.53%

2

2. Health

2.1 Basic Checks

XPOF has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for XPOF has been reduced compared to 1 year ago.
XPOF has a worse debt/assets ratio than last year.

2.2 Solvency

XPOF has an Altman-Z score of -0.10. This is a bad value and indicates that XPOF is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.10, XPOF is doing worse than 82.22% of the companies in the same industry.
The Debt to FCF ratio of XPOF is 105.42, which is on the high side as it means it would take XPOF, 105.42 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 105.42, XPOF is in line with its industry, outperforming 42.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 105.42
Altman-Z -0.1
ROIC/WACC1.37
WACC9.66%

2.3 Liquidity

XPOF has a Current Ratio of 0.93. This is a bad value and indicates that XPOF is not financially healthy enough and could expect problems in meeting its short term obligations.
XPOF has a Current ratio (0.93) which is in line with its industry peers.
A Quick Ratio of 0.79 indicates that XPOF may have some problems paying its short term obligations.
XPOF's Quick ratio of 0.79 is in line compared to the rest of the industry. XPOF outperforms 44.44% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.79

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 133.68% over the past year.
XPOF shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.41%.
Measured over the past years, XPOF shows a very strong growth in Revenue. The Revenue has been growing by 39.98% on average per year.
EPS 1Y (TTM)133.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.86%
Revenue 1Y (TTM)15.41%
Revenue growth 3Y44.05%
Revenue growth 5Y39.98%
Sales Q2Q%-1.06%

3.2 Future

Based on estimates for the next years, XPOF will show a very strong growth in Earnings Per Share. The EPS will grow by 120.13% on average per year.
Based on estimates for the next years, XPOF will show a quite strong growth in Revenue. The Revenue will grow by 8.04% on average per year.
EPS Next Y235.75%
EPS Next 2Y161.49%
EPS Next 3Y120.13%
EPS Next 5YN/A
Revenue Next Year1.56%
Revenue Next 2Y5.37%
Revenue Next 3Y8.04%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 38.41, the valuation of XPOF can be described as expensive.
XPOF's Price/Earnings is on the same level as the industry average.
XPOF is valuated rather expensively when we compare the Price/Earnings ratio to 30.95, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 7.49, which indicates a rather cheap valuation of XPOF.
Based on the Price/Forward Earnings ratio, XPOF is valued cheaply inside the industry as 95.56% of the companies are valued more expensively.
XPOF is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.34, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 38.41
Fwd PE 7.49

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XPOF is on the same level as its industry peers.
XPOF's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 189.08
EV/EBITDA 11.76

4.3 Compensation for Growth

XPOF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XPOF's earnings are expected to grow with 120.13% in the coming years.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y161.49%
EPS Next 3Y120.13%

0

5. Dividend

5.1 Amount

XPOF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

XPONENTIAL FITNESS INC-A

NYSE:XPOF (9/27/2024, 8:04:00 PM)

After market: 12.29 0 (0%)

12.29

+0.05 (+0.41%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap592.01M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 38.41
Fwd PE 7.49
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.92%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 18.25%
PM (TTM) 4.25%
GM 76.74%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.93
Quick Ratio 0.79
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)133.68%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y235.75%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15.41%
Revenue growth 3Y44.05%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y